Teens are daring each other to eat Tide pods. We don ’ t need to tell you that ’ s a bad idea.

First, it was the “gallon challenge” and the “cinnamon challenge.” Then some teenagers started playing the “bath-salt challenge.” They have dared each other to pour salt in their hands and hold ice till it burns, douse themselves in rubbing alcohol and set themselves ablaze, and throw boiling water on unsuspecting peers. Now videos circulating on […]Related:CDC postpones session on ‘preparing for the unthinkable’: a nuclear blastFirst treatment approved for breast cancer with BRCA genetic mutationCDC says, ‘There’s lots of flu in lots of places.’ And it’s not going away anytime soon.
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news

Related Links:

Immunotherapy has already revolutionized cancer care. Combining various immunotherapies promises even greater success, but will the already high cost of these therapies put combos out of reach?Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
PROSTATE cancer symptoms don ’t always appear in the early stages until the tumour has grown and put pressure on other parts of the body. When this happens, pain in certain parts of the body may begin to show.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Authors: Zhang Z, Qi Y, Kong W, Jin Q, Wang X, Dong Y, Wang Y, Li H Abstract BACKGROUND The aim of this study was to investigate the efficacy and clinical value of liraglutide for the treatment of patients with diabetes mellitus (DM) complicated by non-alcoholic fatty liver disease (NAFLD). MATERIAL AND METHODS Patients with DM complicated by NAFLD (n=835) were enrolled. Patients were divided into 2 groups: 424 patients were included in the liraglutide group and 411 patients were included in the conventional drug group. Venous blood was collected to test blood glucose levels, blood lipid levels, and liver function....
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Authors: Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Kumar A, Guleria A, Saraf SA Abstract Co-therapy through biotin modified nanoparticles (NPs) of gefitinib (Gnb) and naringenin (Nar) was investigated for its therapeutic and synergistic potential against lung cancer. The biotin-conjugated polymeric NPs (bty-Nar/Gnb) were developed using oil in water emulsion technique and optimized using central composite design. The formulations were subjected to various in vitro (A549 cell lines) and in vivo evaluations in urethane-induced lung cancer. Co-administration of Gnb and Nar NPs displayed a signific...
Source: Artificial Cells, Nanomedicine and Biotechnology - Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research
PROSTATE cancer symptoms don ’t always appear in the early stages until the tumour has grown and put pressure on other parts of the body. When this happens, pain in certain parts of the body may begin to show.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
After a double mastectomy, Catherine Guthrie wanted to retain her strength and challenge the idea of feminine norms.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Breast Cancer Women and Girls Mastectomy Surgery and Surgeons Muscles Source Type: news
ConclusionCRS/HIPEC is a safe and effective approach in selected patients with PM of HCC. CRS/HIPEC gives the patient a chance for a good relapse free and overall survival and should be considered as an option.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Publication date: November 2018Source: European Journal of Surgical Oncology, Volume 44, Issue 11Author(s): Declan Dunne, Claire Knowles
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Publication date: November 2018Source: European Journal of Surgical Oncology, Volume 44, Issue 11Author(s): Liz Baker, Norma Robinson, Mohamed Tabaqchali, David Leaper
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Publication date: November 2018Source: European Journal of Surgical Oncology, Volume 44, Issue 11Author(s): Liz Baker, Louise Hall, Deborah Wilson, Pud Bhaskar
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Alcoholism | Breast Cancer | Burns | Cancer | Cancer & Oncology | Cancer in Adolescents | Genetics | Health | Sodium Chloride